C. Karaca Et Al. , "Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response," ANTIVIRAL THERAPY , vol.18, no.4, pp.561-566, 2013
Karaca, C. Et Al. 2013. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response. ANTIVIRAL THERAPY , vol.18, no.4 , 561-566.
Karaca, C., Soyer, O. M., Baran, B., Ormeci, A., Gokturk, S., Aydin, E., ... Evirgen, S.(2013). Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response. ANTIVIRAL THERAPY , vol.18, no.4, 561-566.
Karaca, Cetin Et Al. "Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response," ANTIVIRAL THERAPY , vol.18, no.4, 561-566, 2013
Karaca, Cetin Et Al. "Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response." ANTIVIRAL THERAPY , vol.18, no.4, pp.561-566, 2013
Karaca, C. Et Al. (2013) . "Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response." ANTIVIRAL THERAPY , vol.18, no.4, pp.561-566.
@article{article, author={Cetin Karaca Et Al. }, title={Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response}, journal={ANTIVIRAL THERAPY}, year=2013, pages={561-566} }